Morning Movers
Watch us on YouTube Live at 8:30AM EST

Squeeze Stocks – By far the lowest premarket volume since the rally began for this group this morning, no significant additional news catalyst today either. Bloomberg reported yesterday that AMC Entertainment was nearing a deal that could see it acquire Pacific screens in California as well as the acquisition of multiplexes at the Grove and Americana appears imminent. AMC, BB, CLOV, RCON, GME, CLVS

FSR.NY 2.09%
Fisker Inc – Announced it has signed a long-term manufacturing agreement with Canada’s Magna International Inc. Fisker and Magna also confirmed that production of the all-electric Fisker Ocean SUV is projected to start on Nov. 17, 2022

CVAC.NQ -45.93%
CureVac NV – The German biotech’s shares were cut in half overnight after the company released late stage trial data on its COVID-19 vaccine that showed it was only 47% effective.

ORPH.NQ -10.36%
Orphazyme AS – Actively traded premarket again this morning as the Danish drug developer awaits the U.S. FDA’s decision on its genetic disorder drug. The FDA is set to decide on whether to approve the company’s lead candidate, arimoclomol, to treat Niemann-Pick Disease Type C.

MSFT.NQ -0.53%
Microsoft Corp – Big tech lower as a group this morning, Microsoft announced CEO Satya Nadella is now also the company’s chair, becoming the first person since Bill Gates to hold both roles at the same time.

RUN.NQ 5.59%
Sunrun Inc – Clean energy stock looking to extend a 2 session rally, Morgan Stanley upgraded the stock yesterday calling it the ‘most compelling clean energy stock,’ sees shares doubling.

WKHS.NQ 0.67%
Workhorse Group Inc – Trading higher premarket after yesterday’s rally, the company is reportedly preparing a legal challenge to the USPS decision to award vehicle contract to Oshkosh.

KULR.AM 70.04%
KULR Technology Group – Small-cap electrical component maker up nearly 100% in early trading after receiving a special permit from the U.S. Dot authorizing transport of prototype lithium cells and batteries for commerce.

MTP.NQ 52.94%
Midatech Pharma PLC – Announced breakthrough in vitro data demonstrating its Q-Sphera’s technology potential to formulate proteins into long-acting injectable products, as well as significant progress across multiple other programmes.

Leave a Reply

Your email address will not be published.